(Q35138036)

6 August 2017

title

Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients (English)

1 reference

6 August 2017

Richard P Dutton

1

1 reference

6 August 2017

John R Hess

series ordinal

2

1 reference

6 August 2017

Thomas M Scalea

series ordinal

3

1 reference

6 August 2017

publication date

1 May 2003

1 reference

Journal of Clinical Anesthesia

6 August 2017

published in

1 reference

6 August 2017

volume

15

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

184-188

1 reference

Epidemiology of trauma deaths: a reassessment

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Role of ultrasonography in penetrating abdominal trauma: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Recombinant activated factor VII for adjunctive hemorrhage control in trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Treatment of traumatic bleeding with recombinant factor VIIa.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Initiation and regulation of tissue factor-dependent blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Potential role for rFVIIa in transfusion medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Platelet activity of high-dose factor VIIa is independent of tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2803%2900034-5

7 January 2021

10.1016/S0952-8180(03)00034-5

Identifiers

DOI

1 reference

6 August 2017

1 reference